These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 1435881

  • 1. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.
    Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH.
    N Engl J Med; 1992 Nov 26; 327(22):1549-55. PubMed ID: 1435881
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S.
    N Engl J Med; 2001 Mar 08; 344(10):710-9. PubMed ID: 11236774
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.
    Lindvall O, Widner H, Rehncrona S, Brundin P, Odin P, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC.
    Ann Neurol; 1992 Feb 08; 31(2):155-65. PubMed ID: 1575454
    [Abstract] [Full Text] [Related]

  • 7. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW.
    Mov Disord; 1998 May 08; 13(3):383-93. PubMed ID: 9613726
    [Abstract] [Full Text] [Related]

  • 8. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
    Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D, Brundin P, Frackowiak R, Marsden CD, Odin P.
    Ann Neurol; 1994 Feb 08; 35(2):172-80. PubMed ID: 8109898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
    Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, Rehncrona S, Lindvall O.
    Brain; 2000 Jul 08; 123 ( Pt 7)():1380-90. PubMed ID: 10869050
    [Abstract] [Full Text] [Related]

  • 12. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.
    N Engl J Med; 2003 Nov 13; 349(20):1925-34. PubMed ID: 14614167
    [Abstract] [Full Text] [Related]

  • 13. Autologous adrenal medullary, fetal mesencephalic, and fetal adrenal brain transplantation in Parkinson's disease: a long-term postoperative follow-up.
    Madrazo I, Franco-Bourland R, Aguilera M, Ostrosky-Solis F, Madrazo M, Cuevas C, Catrejon H, Guizar-Zahagun G, Magallon E.
    J Neural Transplant Plast; 1991 Nov 13; 2(3-4):157-64. PubMed ID: 1782251
    [Abstract] [Full Text] [Related]

  • 14. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.
    N Engl J Med; 1998 Oct 15; 339(16):1105-11. PubMed ID: 9770557
    [Abstract] [Full Text] [Related]

  • 15. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct 15; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.
    Brain; 2005 Oct 15; 128(Pt 10):2240-9. PubMed ID: 15975946
    [Abstract] [Full Text] [Related]

  • 18. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.
    Østergaard K, Sunde N, Dupont E.
    Mov Disord; 2002 Jul 15; 17(4):693-700. PubMed ID: 12210858
    [Abstract] [Full Text] [Related]

  • 19. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
    Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW.
    Arch Neurol; 1999 Feb 15; 56(2):179-87. PubMed ID: 10025423
    [Abstract] [Full Text] [Related]

  • 20. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.
    López-Lozano JJ, Bravo G, Brera B, Millán I, Dargallo J, Salmeán J, Uría J, Insausti J.
    J Neurosurg; 1997 Jun 15; 86(6):931-42. PubMed ID: 9171171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.